GE Healthcare introduced this week its Amersham ECL Prime chemiluminescent Western blotting reagent.
Offering stable signal emission up to three hours after the addition of the reagent, ECL Prime allows for repeated exposure, making it easier to process several blots on the same run, the company said. Its high signal intensity allows for protein detection using more dilute antibodies, reducing background noise and reagent costs.
Phenomenex announced this week the addition of two new phases – Kinetex XB-C18 and Kinetex C8 – to its Kinetex core shell HPLC/UHPLC column line.
The XB-C18 incorporates two iso-butyl side chains at the base of the C18 ligand to reduce secondary interactions with residual silanols, the company said. The C8 columns meet the United States Pharmacopeia specifications for Classification Code L7, allowing their adoption by labs using L7 columns.
Both columns are available in 2.6-micron and 1.7-micron sizes and in a variety of dimensions.